L&G Pharma Breakthrough UCITS ETF
ETLI.DE
#3088
ETF rank
A$28.92 M
Marketcap
๐Ÿ‡ช๐Ÿ‡บ EU
Market
A$19.61
Share price
-0.19%
Change (1 day)
15.07%
Change (1 year)

Expense ratio and fees for L&G Pharma Breakthrough UCITS ETF (ETLI.DE)

Total Expense Ratio

Total Expense Ratio as of November 2025: 0.49%

ter

ter as of January 2026: 0.49%